BioMérieux Recalls Oxidase Reagent Due to Temperature Excursion in Guadeloupe
BioMérieux is recalling Oxidase Reagent (ref: 55635) in Guadeloupe after a shipment experienced temperature excursions up to 47.8°C, exceeding acceptable limits.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity. The hazard involves a temperature excursion that may compromise the reagent's efficacy, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
BioMérieux SA is recalling 4 boxes of Oxidase Reagent (ref: 55635), containing 50 bottles of 0.75 mL each, with lot number 92366601. This product is a medical device used to detect the production of the enzyme cytochrome oxidase by bacteria, aiding in the differentiation and identification of microorganisms for disease diagnosis.
The recall was initiated because a shipment to Guadeloupe suffered temperature excursions up to 47.8°C, which exceeded the acceptable limits for the product. After the issue was detected, Global Supply Chain QA requested that the BioMérieux distributor in Guadeloupe place the products in quarantine in July 2017. However, after several reminders, the distributor informed the company in November 2017 that the products had already been delivered to customers.
The affected products were distributed internationally, specifically to customers in Guadeloupe. Users of this product should stop using the recalled lot and contact their supplier or BioMérieux for further instructions on disposal or replacement.
The recalled product
- Product
- Oxidase Reagent (ref: 55635): This test is used to detect the production of the enzyme cytochrome oxidase by bacteria. This enzyme is characteristic of the genus Neisseria and most species of Pseudomonas. It enables the differentiation of Gram (-) bacilli (1, 2). A…
- Manufacturer
- BioMerieux SA
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Oxidase Reagent (ref: 55635): Lot number 92366601
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 9 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux Recalls VITEK 2 Gram-Positive Cards Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
Similar recalls
- ModerateBiomerieux BIOBALL P.AERUGINOSA Quality Control Product Recalled for Temperature Excursion
FDA (Devices) · 2023-01-11
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModeratebioMérieux Recalls BacT/ALERT FA Culture Bottles Due to Shipping Exposure
FDA (Devices) · 2016-02-10
- ModeratebioMérieux Recalls BacT/ALERT SN Culture Bottles Due to Shipping Exposure
FDA (Devices) · 2016-02-10
- HighFDA Recalls Reagent Nozzle Cleaning Solution Due to Storage Temperature Exceedance
FDA (Devices) · 2023-01-11
- HighFDA Recalls ASTUTE Electronic Quality Control Device for Storage Condition Excursion
FDA (Devices) · 2023-01-11